Fisher & Paykel Healthcare Corporation Limited Enterprise Value to EBITDA (EV/EBITDA) on July 29, 2025

Fisher & Paykel Healthcare Corporation Limited Enterprise Value to EBITDA (EV/EBITDA) is NA on July 29, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Fisher & Paykel Healthcare Corporation Limited 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 63.85 on July 29, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Fisher & Paykel Healthcare Corporation Limited 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 49.20 on July 29, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Fisher & Paykel Healthcare Corporation Limited average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 56.73.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization